Cognition Therapeutics (CGTX) Cash from Operations (2020 - 2026)
Cognition Therapeutics (CGTX) reported Cash from Operations of 5542000.0 for Q1 2026, up 43.89% year-over-year from 3851557.42 in Q1 2025, and down 61.25% on a QoQ basis from 3437000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 7 years of Cash from Operations data on file, last reported at 5542000.0 in Q1 2026.
- Quarterly Cash from Operations rose 43.89% year-over-year to 5542000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20253000.0 (up 34.89% YoY) and the FY2025 annual result came in at 24588000.0, up 13.65% from the prior year.
- Cash from Operations slipped to 5542000.0 in Q1 2026 per CGTX's latest filing, from 3437000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 4000.0 in Q3 2022 and bottomed at 10184000.0 in Q4 2022.
- The 5-year median for Cash from Operations is 5542000.0 (2026), against an average of 5479705.88.
- The widest annual swing landed in 2022, when Cash from Operations soared 99.8%; it then tumbled 103925.0% in 2023.
- Tracing CGTX's Cash from Operations over 5 years: stood at 10184000.0 in 2022, then surged by 46.43% to 5456000.0 in 2023, then plunged by 53.63% to 8382000.0 in 2024, then jumped by 59.0% to 3437000.0 in 2025, then plunged by 61.25% to 5542000.0 in 2026.
- Per Business Quant, the three latest CGTX Cash from Operations figures stand at 5542000.0 (Q1 2026), 3437000.0 (Q4 2025), and 5651000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 1.08 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | -5.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.54 Mn |
| Mar 31, 2026 | -5.54 Mn |
| Dec 31, 2025 | -3.44 Mn |
| Dec 31, 2025 | -3.44 Mn |
| Sep 30, 2025 | -5.65 Mn |
| Sep 30, 2025 | -5.65 Mn |
| Jun 30, 2025 | -5.62 Mn |
| Jun 30, 2025 | -5.62 Mn |
| Mar 31, 2025 | -9.88 Mn |
| Mar 31, 2025 | -9.88 Mn |
| Dec 31, 2024 | -8.38 Mn |
| Dec 31, 2024 | -8.38 Mn |
| Sep 30, 2024 | -6.85 Mn |
| Sep 30, 2024 | -6.85 Mn |
| Jun 30, 2024 | -6.00 Mn |
| Jun 30, 2024 | -6.00 Mn |
| Mar 31, 2024 | -7.24 Mn |
| Mar 31, 2024 | -7.24 Mn |
| Dec 31, 2023 | -5.46 Mn |
| Dec 31, 2023 | -5.46 Mn |
| Sep 30, 2023 | -4.16 Mn |
| Sep 30, 2023 | -4.16 Mn |
| Jun 30, 2023 | -3.70 Mn |
| Jun 30, 2023 | -3.70 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Mar 31, 2023 | -2.71 Mn |
| Dec 31, 2022 | -10.18 Mn |
| Dec 31, 2022 | -10.18 Mn |
| Sep 30, 2022 | -4,000.00 |
| Sep 30, 2022 | -4,000.00 |
| Jun 30, 2022 | -5.36 Mn |
| Jun 30, 2022 | -5.36 Mn |
| Mar 31, 2022 | -2.99 Mn |
| Mar 31, 2022 | -2.99 Mn |
| Dec 31, 2021 | 101,000.00 |
| Dec 31, 2021 | 101,000.00 |
| Sep 30, 2021 | -2.05 Mn |
| Sep 30, 2021 | -2.05 Mn |
| Jun 30, 2021 | -910,000.00 |
| Jun 30, 2021 | -910,000.00 |
| Mar 31, 2021 | -772,000.00 |
| Mar 31, 2021 | -772,000.00 |
| Dec 31, 2020 | -480,000.00 |
| Dec 31, 2020 | -480,000.00 |